Dividends & Buybacks ·
Curis, Inc. implemented a 1-for-20 reverse stock split of its issued and outstanding common stock, effective July 2…
CRISCuris Inc
Curis, Inc. implemented a 1-for-20 reverse stock split of its issued and outstanding common stock, effective July 2, 2026, at 5:00 p.m. ET. The split will adjust outstanding warrants, restricted stock units, and stock options, including their corresponding exercise prices. Trading on a reverse split-adjusted basis will commence on July 6, 2026, under the existing ticker symbol CRIS. Curis, Inc. is a biotechnology company focused on developing clinical-stage oncology treatments.